Results analysis from Kepler Trust Intelligence

RNS Number : 1965W
NB Global Monthly Income Fund Ltd
21 April 2021
 

NB Global Monthly Income Fund (NBMI)

21/04/2021

 

Results analysis from Kepler Trust Intelligence

NB Global Monthly Income Fund (NBMI) reported results for the year ending 31 December on Tuesday 20 April 2021. During the year the strategy and name of the investment trust changed, allowing the manager to invest across traditional and alternative credit, including in privately arranged debt.

NBMI's results reflect almost three quarters under the old strategy. From the change of strategy to the end of the year, NAV total returns were 4.91%, considerably better than the -1.83% reported for the sterling share class for the 31/12/2020 - 08/09/2021 period. The dividends paid under the new strategy also rose in the later period.

Kepler View

NBMI's latest results show promising returns from the new strategy. This has been aided by the market environment, with positive results from vaccine trials kicking off a rally in credit markets in the final quarter of 2020 and the first quarter of 2021. However, the flexibility of the new mandate meant that the managers have been able to invest in bonds with higher credit risk to take advantage of the rally, and has also allowed the portfolio to make good returns from investing in special situations where an improving economic environment can help a company.

As well as the flexibility of the mandate, the monthly dividend and fee cut are other potentially advantageous changes to the mandate which could increase the attractiveness of the shares.

We note that while the trust's shares have traded on a persistent discount to NAV, there is more potential protection on that account under the new mandate…

CLICK HERE TO READ THE FULL REPORT

 

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

Important information

This report has been issued by Kepler Partners LLP.  The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.  

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 9/10 Savile Row, London W1S 3PF with registered number OC334771.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFFLFLFZLZBBV
UK 100

Latest directors dealings